WestGene Biopharma is proud to announce that its mRNA therapeutic cancer vaccine, WGc-043, has received dual IND approvals from China's National Medical Products

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. and Guangdong JiAnTeBo Biotechnology Co., Ltd. have signed a strategic cooperation agreement. Under the leadership of Professor

Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced a strategic

Nasus Pharma Ltd, a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based Intranasal (PBI) product portfolio, to address acute medical conditions

Imbrium Therapeutics L.P., a subsidiary of Purdue Pharma L.P. (“Purdue”), has submitted an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) to evaluate sunobinop for the potential treatment of moderate to severe alcohol use disorder (AUD)*.

Cognigenics, a pioneering company in RNA-based therapeutics for neuropsychiatric conditions and neurocognitive disorders, announced the publication of its latest research, Treatment with shRNA

Ocugen, Inc., a biotechnology company specializing in gene and cell therapies and vaccines, has received FDA approval for its expanded access program (EAP) for adult patients aged 18 and older with retinitis pigmentosa (RP) to access OCU400, a gene therapy candidate.

The U.S. Food and Drug Administration has approved Tecelra for the treatment of adults with unresectable or metastatic synovial sarcoma who have previously received chemotherapy

Jade Biosciences, Inc., a biotech company focused on innovative treatments for autoimmune diseases, has announced the successful completion of an $80 million financing round. This round was led by Fairmount and Venrock Healthcare Capital Partners

Celltrion Healthcare Canada Limited has announced that Steqeyma® (ustekinumab injection) and Steqeyma® I.V. (ustekinumab for injection, solution for intravenous infusion) have been approved by Health Canada.